List of works - Mei-Hsuan Tseng

A single-tube, sensitive multiplex method for screening of isocitrate dehydrogenase 1 (IDH1) mutations.

scientific article published on July 2010

AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.

scientific article published on 6 October 2009

An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype.

scientific article published on 23 October 2015

Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia

scientific article

Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.

scientific article

Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.

scientific article

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.

scientific article published on 22 January 2010

Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations

scientific article published on 06 August 2010

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).

scientific article published on 04 August 2016

Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome.

scientific article

Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia

scientific article published on 29 September 2007

GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution

scientific article published on 21 September 2014

GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia

scientific article published on 31 August 2018

Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia

scientific article

Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients.

scientific article published on 6 April 2018

IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution

scientific article published on 20 November 2013

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.

scientific article published on 4 April 2018

Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution

scientific article published on 01 March 2006

Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia

scientific article published on 29 December 2017

RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome

scientific article published on 01 November 2007

SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution.

scientific article

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia

scientific article published on 24 January 2016

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

scientific article

The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression

scientific article

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution

scientific article published on 29 August 2012

The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model

scientific article

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome

scientific article published on 13 August 2018

List of works by Mei-Hsuan Tseng

A single-tube, sensitive multiplex method for screening of isocitrate dehydrogenase 1 (IDH1) mutations.

AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.

An mRNA expression signature for prognostication in de novo acute myeloid leukemia patients with normal karyotype.

Clinical and prognostic implications of Roundabout 4 (robo4) in adult patients with acute myeloid leukemia

Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression.

Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.

Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations

Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS).

Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome.

Expression of angiopoietins and vascular endothelial growth factors and their clinical significance in acute myeloid leukemia

GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution

GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia

Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemia

Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients.

IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.

Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution

Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia

RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome

SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution.

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia

TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics

The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression

The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution

The distinct biological implications of Asxl1 mutation and its roles in leukemogenesis revealed by a knock-in mouse model

The prognostic significance of global aberrant alternative splicing in patients with myelodysplastic syndrome